Type

Journal Article

Authors

Sally-Ann Cryan
Paul J Gallagher
Seonadh O'Leary
Gemma O'Connor
Ciaran Lawlor
Mary O'Sullivan
Joseph Keane

Subjects

Microbiology

Topics
plga microparticles multiple drug restistant tb tuberculosis nanoscience materials drug delivery systems mycobacterium tuberculosis poly lactic acid immunology inflammation infection

Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NF?B and Autophagy Dependent Bacillary Killing (2016)

Abstract The emergence of multiple-drug-resistant tuberculosis (MDR-TB) has pushed our available repertoire of anti-TB therapies to the limit of effectiveness. This has increased the urgency to develop novel treatment modalities, and inhalable microparticle (MP) formulations are a promising option to target the site of infection. We have engineered poly(lactic-co-glycolic acid) (PLGA) MPs which can carry a payload of anti-TB agents, and are successfully taken up by human alveolar macrophages. Even without a drug cargo, MPs can be potent immunogens; yet little is known about how they influence macrophage function in the setting of Mycobacterium tuberculosis (Mtb) infection. To address this issue we infected THP-1 macrophages with Mtb H37Ra or H37Rv and treated with MPs. In controlled experiments we saw a reproducible reduction in bacillary viability when THP-1 macrophages were treated with drug-free MPs. NFκB activity was increased in MP-treated macrophages, although cytokine secretion was unaltered. Confocal microscopy of immortalized murine bone marrow-derived macrophages expressing GFP-tagged LC3 demonstrated induction of autophagy. Inhibition of caspases did not influence the MP-induced restriction of bacillary growth, however, blockade of NFκB or autophagy with pharmacological inhibitors reversed this MP effect on macrophage function. These data support harnessing inhaled PLGA MP-drug delivery systems as an immunotherapeutic in addition to serving as a vehicle for targeted drug delivery. Such “added value” could be exploited in the generation of inhaled vaccines as well as inhaled MDR-TB therapeutics when used as an adjunct to existing treatments.
Collections Ireland -> Trinity College Dublin -> RSS Feeds
Ireland -> Trinity College Dublin -> Clinical Medicine
Ireland -> Trinity College Dublin -> Clinical Medicine (Scholarly Publications)
Ireland -> Trinity College Dublin -> RSS Feeds
Ireland -> Trinity College Dublin -> School of Medicine

Full list of authors on original publication

Sally-Ann Cryan, Paul J Gallagher, Seonadh O'Leary, Gemma O'Connor, Ciaran Lawlor, Mary O'Sullivan, Joseph Keane

Experts in our system

1
Sally-Ann Cryan
Royal College of Surgeons in Ireland
Total Publications: 70
 
2
Paul J Gallagher
Royal College of Surgeons in Ireland
 
3
Seonadh O'Leary
Trinity College Dublin
Total Publications: 12
 
4
Gemma O'Connor
Royal College of Surgeons in Ireland
Total Publications: 5
 
5
Ciaran Lawlor
Royal College of Surgeons in Ireland
Total Publications: 8
 
6
Mary P O'Sullivan
Trinity College Dublin
Total Publications: 19
 
7
Joseph Keane
Trinity College Dublin
Total Publications: 54